Grant: Discovery Grants Program - Individual
Ryerson University
$28,580.00
Quantification of some trace elements in humans
EF 2008-09
Résumé
This research concentrates on the further development, evaluation, validation and application of the new techniques for in vivo measurements of trace and toxic elements in human bone. Measurements are non-invasive, no sample is taken, nor is there discomfort to the patient. A beneficial effect of low strontium doses has been recently found in osteoporosis patients. At intermediate and high doses, strontium can induce diseases such as osteomalacia in renal patients and rickets in children. The in vivo X-ray fluorescence technique has been developed to measure strontium stored in the bone. We would like to further develop and improve the sensitivity of the technique, and facilitate its clinical application to benefit patients suffering from osteoporosis. Aluminum and manganese are toxic elements. It is documented that increased aluminum levels are detected in dialysis patients causing a variety of health problems and deaths. Furthermore, it has been vigorously debated whether aluminum in any form is associated with Alzheimer's disease. Manganese is essential to human life, in particular, to neurological and skeletal functions. Exposure to manganese at low levels for a prolonged period of time can result in milder neurological symptoms than those seen in manganism, Parkinson's disease like syndrome: including memory deficit, loss of motor control and reduction in the refinement of certain bodily motions. To measure the elements concentration, in vivo neutron activation analysis of bone is developed using a low-energy accelerator. A critical feature of this technique is that the interfering reactions are not energetically permitted. This research project focuses on, but is not limited to: a further system development and an in vivo pilot study of the new techniques of in vivo measurements of elements in human bone.
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
249583-2006
Name nom
PejovicMilic, Ana
Department département
Physics
Organization id
43
Institution établissement
Ryerson University
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2008
Competition year année de concours
2006
Award amount
28580
Program id
RGPIN
Program nane en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
21
Committee name en
Interdisciplinary
Committee name fr
Interdisciplinaire
Area of application code
518
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Medical equipment and apparatus
Area of application fr
Appareils et instruments médicaux
Research subject code
3114
Research subject group en
Physics
Research subject group fr
Physique
Research subject en
Biological and Medical Physics
Research subject fr
Physique biologique et médicale
Partie
3
Nb partie
5
Application title
Quantification of some trace elements in humans
Keyword
NA
Application summary
This research concentrates on the further development, evaluation, validation and application of the new techniques for in vivo measurements of trace and toxic elements in human bone. Measurements are non-invasive, no sample is taken, nor is there discomfort to the patient. A beneficial effect of low strontium doses has been recently found in osteoporosis patients. At intermediate and high doses, strontium can induce diseases such as osteomalacia in renal patients and rickets in children. The in vivo X-ray fluorescence technique has been developed to measure strontium stored in the bone. We would like to further develop and improve the sensitivity of the technique, and facilitate its clinical application to benefit patients suffering from osteoporosis. Aluminum and manganese are toxic elements. It is documented that increased aluminum levels are detected in dialysis patients causing a variety of health problems and deaths. Furthermore, it has been vigorously debated whether aluminum in any form is associated with Alzheimer's disease. Manganese is essential to human life, in particular, to neurological and skeletal functions. Exposure to manganese at low levels for a prolonged period of time can result in milder neurological symptoms than those seen in manganism, Parkinson's disease like syndrome: including memory deficit, loss of motor control and reduction in the refinement of certain bodily motions. To measure the elements concentration, in vivo neutron activation analysis of bone is developed using a low-energy accelerator. A critical feature of this technique is that the interfering reactions are not energetically permitted. This research project focuses on, but is not limited to: a further system development and an in vivo pilot study of the new techniques of in vivo measurements of elements in human bone.